Medicare Compliance & Reimbursement - 2009 Issue 34
PART B CODING COACH: CPT 2010 Preview: Getting Paid Per Drug Class for Test Kits? That's About to End
Subscribe or sign in to view the full article.
Article Overview
This article explains a proposed shift in how Medicare pays for laboratory drug screen testing and why the change matters for labs that bill these services. It covers the move from existing CPT drug screen codes to new HCPCS G codes, the role of CLIA-waived testing, and the CMS process for proposed and final payment determinations. The piece is aimed at laboratory coders, billing staff, and compliance professionals following 2010 coding updates and fee schedule changes.
Why This Topic Matters
The article helps readers understand upcoming Medicare payment changes for drug screen testing and the administrative steps tied to CMS pricing. It is relevant to labs that need to track code transitions, payment updates, and public comment timelines.
Article Sections
-
Drug screen payment issue
Introduces the Medicare payment concern affecting laboratory drug screen testing and the broader context for the proposed changes.
-
Drug screens aren't equal
Explains the current coding landscape for drug screen testing and the category of laboratory services involved.
-
Problem
Describes the existing CPT framework used for billing drug screen services and the related CLIA-waived testing context.
-
G Codes Create Drug Class Division
Covers the proposed HCPCS G code replacement structure and the CMS rationale for separating categories of drug screening services.
-
Heads up for pay changes
Addresses anticipated fee schedule effects and the possibility of changes to existing Medicare payment handling.
-
Comment on Pricing Proposal by October
Summarizes CMS timing for proposed payment postings, public comments, and final determinations.
-
Expect crosswalk
Notes the Medicare pricing methodologies discussed for the new codes and the general preference reported at the public meeting.
What You Will Learn
- How Medicare payment policy is changing for laboratory drug screen testing
- Which code families are involved in the transition from existing CPT codes to HCPCS G codes
- How CLIA-waived testing fits into the broader coding discussion
- What CMS timing and comment opportunities are associated with the proposed pricing
- What general payment methodologies are being discussed for the new codes
Who Should Read This
- Laboratory coders
- Medical billers
- Revenue cycle staff
- Compliance professionals
- Clinical laboratory administrators
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com